Skip to content

Other Income (Expense) at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$8.47M-678%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$6M-40.0%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.26M+112%
Incyte logo
IncyteINCY
$2.77M-65.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$563M-760%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$8.16M-39.8%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.8B+674%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s other income (expense)?
SELLAS Life Sciences Group, Inc. (SLS) reported other income (expense) of $845K in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s other income (expense) changed year-over-year?
SELLAS Life Sciences Group, Inc.'s other income (expense) increased by 238.0% year-over-year, from $250K to $845K.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s other income (expense) has grown at a -24.6% compound annual growth rate (CAGR), from $4.36M to $1.41M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.